Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Carlier

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Nanomaterials (Basel, Switzerland)|October 27, 2022
Spatially-Localized Functionalization on Nanostructured Surfaces for Enhanced Plasmonic Sensing EfficacyJean-François Bryche, Marlo Vega, Agnès Tempez, et al.
Cancers|February 26, 2020
Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple MyelomaBastien Jamet, Clément Bailly, Thomas Carlier, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|January 16, 2025
PET-based lesion graphs meet clinical data: An interpretable cross-attention framework for DLBCL treatment response predictionOriane Thiery, Mira Rizkallah, Clément Bailly, et al.
Cancers|June 3, 2020
FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?Anne-Victoire Michaud-Robert, Bastien Jamet, Clément Bailly, et al.
EJNMMI Research|February 19, 2013
Assessment of acquisition protocols for routine imaging of Y-90 using PET/CTThomas Carlier, Thomas Eugène, Caroline Bodet-Milin, et al.
International Journal of Molecular Sciences|August 6, 2020
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple MyelomaBastien Jamet, Elena Zamagni, Cristina Nanni, et al.
Cancers|September 5, 2019
Exploring Tumor Heterogeneity Using PET Imaging: The Big PictureClément Bailly, Caroline Bodet-Milin, Mickaël Bourgeois, et al.
Oncotarget|November 5, 2017
Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumorsBastien Jamet, Thomas Carlier, Loic Campion, et al.
Scientific Reports|October 24, 2023
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trialCaroline Bodet-Milin, Cyrille Morvant, Thomas Carlier, et al.
Frontiers in Medicine|August 11, 2015
Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-UpDaniela Rusu, Thomas Carlier, Mathilde Colombié, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Nanomaterials (Basel, Switzerland)|October 27, 2022
Spatially-Localized Functionalization on Nanostructured Surfaces for Enhanced Plasmonic Sensing EfficacyJean-François Bryche, Marlo Vega, Agnès Tempez, et al.
Cancers|February 26, 2020
Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple MyelomaBastien Jamet, Clément Bailly, Thomas Carlier, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|January 16, 2025
PET-based lesion graphs meet clinical data: An interpretable cross-attention framework for DLBCL treatment response predictionOriane Thiery, Mira Rizkallah, Clément Bailly, et al.
Cancers|June 3, 2020
FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?Anne-Victoire Michaud-Robert, Bastien Jamet, Clément Bailly, et al.
EJNMMI Research|February 19, 2013
Assessment of acquisition protocols for routine imaging of Y-90 using PET/CTThomas Carlier, Thomas Eugène, Caroline Bodet-Milin, et al.
International Journal of Molecular Sciences|August 6, 2020
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple MyelomaBastien Jamet, Elena Zamagni, Cristina Nanni, et al.
Cancers|September 5, 2019
Exploring Tumor Heterogeneity Using PET Imaging: The Big PictureClément Bailly, Caroline Bodet-Milin, Mickaël Bourgeois, et al.
Oncotarget|November 5, 2017
Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumorsBastien Jamet, Thomas Carlier, Loic Campion, et al.
Scientific Reports|October 24, 2023
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trialCaroline Bodet-Milin, Cyrille Morvant, Thomas Carlier, et al.
Frontiers in Medicine|August 11, 2015
Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-UpDaniela Rusu, Thomas Carlier, Mathilde Colombié, et al.
Pageof 9